Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Population-scale chemical response revealed by a barcoded yeast collection.

Nature communications·2026
Same author

A Physics-Informed Neural Network (PINN) Approach to Over-Equilibrium Dynamics in Conservatively Perturbed Linear Equilibrium Systems.

Entropy (Basel, Switzerland)·2026
Same author

Domestication drives repeated evolution of sexual-asexual life cycle trade-offs in yeast.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

An empirical long-term competition among natural yeast isolates reveals that short-term fitness largely but not entirely predicts long-term outcomes.

bioRxiv : the preprint server for biology·2025
Same author

Shaping robust dynamic inversion control of neural cell dynamics.

Biomedical physics & engineering express·2025
Same author

Developing a Zn(II)-metallovesicle for loading and delivering doxorubicin to kill cancer cells-a multi-drug delivery system.

Chemical communications (Cambridge, England)·2025

相关实验视频

Updated: Jul 9, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K

对BCG免疫治疗的重组多目标对照.

Rongting Yue1, Abhishek Dutta2

  • 1Electrical and Computer Engineering, University of Connecticut, Storrs, 06269, USA. rongting.yue@uconn.edu.

Scientific reports
|November 27, 2023
PubMed
概括
此摘要是机器生成的。

优化卡尔梅特和瓜林杆菌 (BCG) 免疫疗法药物剂量,通过一种新的重定型多目标控制方法,有效地消除了膀癌细胞. 这种方法为基于模型的先进癌症治疗设计提供了潜在的框架.

更多相关视频

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.3K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.0K

相关实验视频

Last Updated: Jul 9, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.3K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.0K

科学领域:

  • 在瘤学瘤学.
  • 免疫治疗是一种免疫疗法.
  • 控制理论 控制理论

背景情况:

  • 膀癌显著影响老年人群.
  • 卡尔梅特和瓜林杆菌 (BCG) 免疫疗法是有效的,但需要最佳的药物剂量.
  • 在膀癌治疗中,设计最佳的BCG疗法仍然是一个挑战.

研究的目的:

  • 为优化BCG药物剂量方案提出和应用重定型多目标控制 (RMC) 方法.
  • 将RMC方法与库普曼模型预测控制 (MPC) 进行比较.
  • 为了验证最佳化BCG剂量在膀癌治疗中的有效性.

主要方法:

  • 使用非线性膀癌模型与冲动药物灌注.
  • 在RMC框架内应用受约束优化.
  • 进行数值模拟,将RMC与Koopman MPC进行比较.

主要成果:

  • 通过RMC方法成功地确定了最佳的BCG剂量方案.
  • 数字模拟表明使用建议的最佳方案有效消除癌细胞.
  • 该RMC方法显示了可比或优于库普曼MPC的性能.

结论:

  • 重定型多目标控制 (RMC) 方法在设计膀癌中最佳的BCG剂量方案方面是有效的.
  • 优化的BCG剂量方案可以有效地消除癌细胞.
  • 拟议的控制框架有可能在基于模型的癌症治疗设计中得到更广泛的应用.